January 6, 2015

Gilead Sciences’ Harvoni and Sovaldi drugs will be exclusive to CVS Health’s Standard Commercial, Exchange (Marketplace), Medicare Part D and Medicaid formularies.

January 6, 2015

Rite Aid named Jocelyn Zazyczny Konrad, currently VP healthcare initiatives, to group VP pharmacy initiatives and clinical services.

 

January 6, 2015

Walgreens on Tuesday announced that December sales increased 10.2% to $7.9 billion.

 

January 6, 2015

As newly insured Americans begin using their 2015 benefits under the Affordable Care Act, Walgreens will again provide medication assistance to those patients who may have difficulty using their new insurance coverage.

January 5, 2015

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a Q&A with Owen Mumford's Travis Shaw, in this multi-page report.

January 5, 2015

CVS Health is now offering talking prescription labels as well as braille and large print labels through its mail service pharmacy to CVS/caremark members who are blind or visually impaired.

January 5, 2015

Rite Aid on Friday posted a December sales increase of 4.9% to $2.2 billion.

 

January 5, 2015

January marks the launch of the fourth annual Medication Adherence Team Challenge, an inter-collegiate competition to raise awareness about medication adherence.

December 29, 2014

Diplomat Pharmacy has announced that Jennifer Hagerman will take office as the president of the Michigan Pharmacists Association.

December 29, 2014

In a staff memo, the Office of Generics Drug’s acting director, Kathleen Uhl, vowed to take action on 90% of the abbreviated new drug application backlog before October 2017, and has appointed Ted Sherwood as acting director of OGD’s Office of Regulatory Operations to help with the improvements, FDANews.com has reported.

December 23, 2014

Specialty pharmaceutical company Actavis has hired Jonathon Kellerman as EVP, global chief compliance officer.

December 23, 2014

Teva Pharmaceutical today announced that the Food and Drug Administration has approved Granix (tbo-filgrastim) Injection for self-administration by patients and caregivers. With the approval of this additional administration option, physicians will soon have the flexibility to prescribe Granix for either in-office or at home use.

December 23, 2014

Shares of Walgreens were on the rise in pre-market trading Tuesday morning, as Walgreens reported a 16.4% lift in quarterly profit to $809 million that was credited to the 222 million prescriptions filled in the first quarter ended Nov. 30.

December 22, 2014

The Food and Drug Administration has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable (cannot be removed by surgery) or metastatic (advanced) melanoma who no longer respond to other drugs.

December 22, 2014

The Food and Drug Administration has approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections and complicated urinary tract infections.

December 19, 2014

Dr. Reddy’s Laboratories has announced that it has closed the acquisition of Habitrol brand — an over-the-counter nicotine replacement therapy transdermal patch — from Novartis Consumer Health.

December 18, 2014

The American Pharmacists Association is reminding the 250 million people who visit the pharmacy each week to utilize their relationship with their neighborhood pharmacist to meet their health care and information needs during the cold and flu season.

December 18, 2014

The CVS Health Research Institute released a first look at the comparative utilization of two new hepatitis C treatments in the weeks following their respective launches.

December 18, 2014

In a letter to the Military Compensation and Retirement Modernization Commission on Thursday, the National Association of Chain Drug Stores emphasized the health-boosting and cost-reducing benefits that the pharmacist-patient relationship can produce for military families and veterans, and for the Department of Defense.

December 18, 2014

The U.S. Senate Special Committee on Aging unveiled a new bipartisan report earlier this week that focuses on ways to increase the use of generic drugs within the Medicare Part D program.

December 18, 2014

UnitedHealthcare has announced the winners of the second annual UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.

December 17, 2014

To date, the Food and Drug Administration's Center for Drug Evaluation and Research has approved 35 novel new drugs in 2014, compared to 27 in 2013. 

December 17, 2014

The Generic Pharmaceutical Association on Wednesday expressed concerns that the current structure of the Trans-Pacific Partnership agreement (TPP) will impede generic utilization.

December 17, 2014

Ipsen Biopharmaceuticals on Tuesday announced that Somatuline Depot (lanreotide) Injection 120 mg (referred to as Somatuline) was approved by the U.S. Food and Drug Administration for the treatment of gastroenteropancreatic neuroendocrine tumors.